
Nanopath
Nanopath is a molecular diagnostics company disrupting traditional testing methodologies. We aim to improve the health of women by providing granular and clinically actionable information within a single office visit.
Growth Trajectory
The company aims for expansion through a focus on developing a broader suite of assessments that address various aspects of women's health, targeting potential global outreach. With supportive funding from the NIH and NSF, there are clear signals of investment in technology advancements and hiring to support growth. Their commitment to innovating diagnostics positions them well within the rapidly evolving healthcare landscape.
Technical Challenges
Tech Stack
Team Size
Key Risks
Opportunities
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats